Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal vs Bolus for Continuous TAP Blocks
NCT02662023Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoint: Sensory Deficit (Cold Roller), Mid-axillary Line at 6 hours. Started Feb 2016; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02662023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662023.